Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Comparison of SARS-CoV-2 Variant Screening and Whole Genome Sequencing at an Indonesian Tertiary Hospitals

Journal of Biomedicine and Translational Research · Vol. 9 No. 3 (2023) · hlm. 111–115

DOI
10.14710/jbtr.v9i3.19147
ISSN
2503-2178
Terbit
2023-12-31
Penerbit
Faculty of Medicine, Universitas Diponegoro
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Background: The global COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), experienced a surge in cases with the emergence of the Omicron variant. Despite increasing vaccination coverage, Indonesia witnessed peaks in COVID-19 cases. Variant screening and whole genome sequencing (WGS) play a crucial role in identifying SARS-CoV-2 variants and monitoring their spread.Objective: The objective of this study was to compare variant screening results with WGS data, assess the prevalence of subvariants, and analyze their correlation with demographic and cycle threshold (CT) values.Methods: Between November 7th and 18th, 2022, variant screening and WGS were conducted on samples with CT values below 30. Variant screening utilized the mBioCov-19+ VarScreen assay, while WGS was performed on the Oxford Nanopore Technologies (ONT) platform. Bioinformatics analysis was performed using epi2melabs. Demographic data and CT values were analyzed. Results: Out of 89 subjects, all tested positive for the Omicron variant through variant screening. The variant screening identified two subvariants: Omicron BA.2 (64%) and Omicron B.1.1.529.1 (36%). WGS revealed that the XBB subvariant was the most dominant (52.8%), followed by BQ.1 (22.5%) and BA.5 (13.5%). When VarScreen indicated BA.2, the majority of WGS results showed XBB (82.5%), while for B.1.1.529.1, the majority of WGS results were BQ.1 (59.4%), followed by BA.5 (37.5%). XBB was the most prevalent variant in both females and males, while BQ.1 was more dominant in females (80%). No infections were detected among children aged 1-5 years. All variants had CT values below 24.Conclusion: Variant screening provides accurate and quick results for detecting the Omicron variant in laboratories without WGS capacity. However, it is important to continuously update the screening methodology based on the prevailing circulating variants. During the study period, XBB emerged as the predominant subvariant of the Omicron variant.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 110 tautan kepenulisan bersama · 29 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • Jenderal Soedirman University
  • Eijkman Institute for Molecular Biology
  • Universitas Jambi
  • Sultan Agung Islamic University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Maria Estela CarolinaAfiliasi tidak diketahui1
MujahidahAfiliasi tidak diketahui1
SubakirAfiliasi tidak diketahui1
Maria Estela KarolinaUniversitas Jambi1
Mujahidah MujahidahAfiliasi tidak diketahui1
Subakir SubakirAfiliasi tidak diketahui1
Edi DharmanaDiponegoro University1
Jonathan Alvin Nugraha HalimDiponegoro University1
Stefanie Natalia HalimDiponegoro University1
Dionisius DenisEijkman Institute for Molecular Biology1
Sotianingsih HaryantoUniversitas Jambi1
R. Tedjo SasmonoEijkman Institute for Molecular Biology1
Benediktus YohanEijkman Institute for Molecular Biology1
Thania Lathifatunnisa Putri AgustiDiponegoro University1
Nahwa ArkhaesiDiponegoro University1
Anugrah RiansariDiponegoro University1
Nani MaharaniDiponegoro University1
Muhammad Thifan SatyagrahaDiponegoro University1
Meita HendrianingtyasDiponegoro University1
Lantip RujitoJenderal Soedirman University1
Gembong Satria MahardhikaJenderal Soedirman University1
Metta Ayu SusantiJenderal Soedirman University1
Muhammad Hussein GasemDiponegoro University1
Tania Tedjo MinuljoDiponegoro University1
Indah Sri WahyuningsihSultan Agung Islamic University1
Fitria Endah JanitraSultan Agung Islamic University1
Sarinti SarintiAfiliasi tidak diketahui1
Muhammad MahfudAfiliasi tidak diketahui1
Failasuf WibisonoAfiliasi tidak diketahui1
Ari AsnaniJenderal Soedirman University1
Annisa Permata DindaJenderal Soedirman University1
Abdi Rahman NursyamsiJenderal Soedirman University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal2.undip.ac.id/index.php/jbtr/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Comparison of SARS-CoV-2 Variant Screening and Whole Genome Sequencing at an Indonesian Tertiary Hospitals</dc:title>
	<dc:creator>Hapsari, Rebriarina</dc:creator>
	<dc:creator>Kesumayadi, Irfan</dc:creator>
	<dc:creator>Sari, Desvita</dc:creator>
	<dc:creator>Anjarwati, Dwi Utami</dc:creator>
	<dc:creator>Alfiyuliani, Nesia Hani</dc:creator>
	<dc:creator>Mujahidah, Mujahidah</dc:creator>
	<dc:creator>Sari, Iva Puspita</dc:creator>
	<dc:creator>Hadi, Purnomo</dc:creator>
	<dc:subject xml:lang="en-US">Variant screening; Whole Genome Sequencing; Omicron; XBB</dc:subject>
	<dc:description xml:lang="en-US">Background: The global COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), experienced a surge in cases with the emergence of the Omicron variant. Despite increasing vaccination coverage, Indonesia witnessed peaks in COVID-19 cases. Variant screening and whole genome sequencing (WGS) play a crucial role in identifying SARS-CoV-2 variants and monitoring their spread.Objective: The objective of this study was to compare variant screening results with WGS data, assess the prevalence of subvariants, and analyze their correlation with demographic and cycle threshold (CT) values.Methods: Between November 7th and 18th, 2022, variant screening and WGS were conducted on samples with CT values below 30. Variant screening utilized the mBioCov-19+ VarScreen assay, while WGS was performed on the Oxford Nanopore Technologies (ONT) platform. Bioinformatics analysis was performed using epi2melabs. Demographic data and CT values were analyzed. Results: Out of 89 subjects, all tested positive for the Omicron variant through variant screening. The variant screening identified two subvariants: Omicron BA.2 (64%) and Omicron B.1.1.529.1 (36%). WGS revealed that the XBB subvariant was the most dominant (52.8%), followed by BQ.1 (22.5%) and BA.5 (13.5%). When VarScreen indicated BA.2, the majority of WGS results showed XBB (82.5%), while for B.1.1.529.1, the majority of WGS results were BQ.1 (59.4%), followed by BA.5 (37.5%). XBB was the most prevalent variant in both females and males, while BQ.1 was more dominant in females (80%). No infections were detected among children aged 1-5 years. All variants had CT values below 24.Conclusion: Variant screening provides accurate and quick results for detecting the Omicron variant in laboratories without WGS capacity. However, it is important to continuously update the screening methodology based on the prevailing circulating variants. During the study period, XBB emerged as the predominant subvariant of the Omicron variant.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Medicine, Universitas Diponegoro</dc:publisher>
	<dc:date>2023-12-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/19147</dc:identifier>
	<dc:identifier>10.14710/jbtr.v9i3.19147</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Biomedicine and Translational Research; Vol 9, No 3 (2023): December 2023; 111-115</dc:source>
	<dc:source>2503-2178</dc:source>
	<dc:source>10.14710/jbtr.v9i3</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/19147/10371</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Journal of Biomedicine and Translational Research</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>